This webinar is part one of a two part series that focuses on clinical trials for ALS in Canada and across the world.
Dr. David Taylor, VP of Research at ALS Canada, explores how clinical trials currently work, the importance of biomarkers, a new way of doing ALS clinical trials and the current state of experimental therapies in Canada and worldwide.
This webinar is offered in English only.